Literature DB >> 8159771

Posttranscriptional modification of myosin heavy-chain gene expression in the hypertrophied rat myocardium.

K Ojamaa1, J F Petrie, C Balkman, C Hong, I Klein.   

Abstract

Hypertrophy of the myocardium in response to pressure or volume overload elicits a change in myofibrillar protein content as a result of changes in both transcriptional and translational regulation of gene expression. Hemodynamic overload caused by aortic constriction produced changes in the expression of the two isoforms of myosin heavy chain (MHC) with a 319% increase in beta-MHC mRNA and a 54% decrease in alpha-MHC mRNA (P < 0.01). Cardiac unloading as a result of heterotopic transplantation resulted in a decrease in cardiac mass and a similar shift in MHC isoform expression. In this study. We investigated cardiac gene transcription to understand how different hemodynamic stimuli produce similar cardiac phenotypes. We studied the in vivo activity of the alpha-MHC promoter (-2564 to +421 bp of the transcriptional start site) by directly injecting a recombinant expression plasmid (pAM3LUC) into the ventricular tissue of coarctated animals as well as into the unloaded heterotopic transplanted heart. When expressed as a function of the activity of a constitutively active viral promoter (pSVCAT), pAM3LUC activities were 18.4 +/- 2.9, 24.6 +/- 2.6, and 25.0 +/- 4.5 (x10(4)) luciferase/chloramphenicol acetyltransferase units in the hypertrophied ventricles of 2-, 3-, and 7-day coarctated animals, respectively. These values were not statistically different from pAM3LUC activity in control hearts of sham operated animals even though alpha-MHC mRNA content was decreased by 54% in the hypertrophied myocardium. This disparity between transcriptional activity and mRNA content suggests that alpha-MHC expression in the hypertrophic ventricle is in part regulated by a posttranscriptional mechanism. In contrast, alpha-MHC promoter activity in the unloaded transplanted hearts decreased significantly by 37% compared to control working hearts and suggests that a transcriptional mechanism of regulation of the alpha-MHC gene may account for the phenotypic expression observed in the unloaded myocardium.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8159771      PMCID: PMC43598          DOI: 10.1073/pnas.91.8.3468

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Selective gene expression in failing human heart. Quantification of steady-state levels of messenger RNA in endomyocardial biopsies using the polymerase chain reaction.

Authors:  A M Feldman; P E Ray; C M Silan; J A Mercer; W Minobe; M R Bristow
Journal:  Circulation       Date:  1991-06       Impact factor: 29.690

2.  The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection.

Authors:  C M Gorman; G T Merlino; M C Willingham; I Pastan; B H Howard
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

3.  Cytoplasmic processing of myosin heavy chain messenger RNA: evidence provided by using a recombinant DNA plasmid.

Authors:  R M Medford; R M Wydro; H T Nguyen; B Nadal-Ginard
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

4.  Antithetical accumulation of myosin heavy chain but not alpha-actin mRNA isoforms during early stages of pressure-overload-induced rat cardiac hypertrophy.

Authors:  C Chassagne; C Wisnewsky; K Schwartz
Journal:  Circ Res       Date:  1993-04       Impact factor: 17.367

5.  Thyroid hormone regulation of alpha-myosin heavy chain promoter activity assessed by in vivo DNA transfer in rat heart.

Authors:  K Ojamaa; I Klein
Journal:  Biochem Biophys Res Commun       Date:  1991-09-30       Impact factor: 3.575

6.  In vivo regulation of recombinant cardiac myosin heavy chain gene expression by thyroid hormone.

Authors:  K Ojamaa; I Klein
Journal:  Endocrinology       Date:  1993-03       Impact factor: 4.736

7.  Molecular characterization of the stretch-induced adaptation of cultured cardiac cells. An in vitro model of load-induced cardiac hypertrophy.

Authors:  J Sadoshima; L Jahn; T Takahashi; T J Kulik; S Izumo
Journal:  J Biol Chem       Date:  1992-05-25       Impact factor: 5.157

8.  Reversible alterations in myocardial gene expression in a young man with dilated cardiomyopathy and hypothyroidism.

Authors:  P W Ladenson; S I Sherman; K L Baughman; P E Ray; A M Feldman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

9.  Regulation of procollagen metabolism in the pressure-overloaded rat heart.

Authors:  E G Eleftheriades; J B Durand; A G Ferguson; G L Engelmann; S B Jones; A M Samarel
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

10.  Thyroid hormone effects on cardiac gene expression independent of cardiac growth and protein synthesis.

Authors:  K Ojamaa; A M Samarel; J M Kupfer; C Hong; I Klein
Journal:  Am J Physiol       Date:  1992-09
View more
  12 in total

Review 1.  Myofibrillar remodeling in cardiac hypertrophy, heart failure and cardiomyopathies.

Authors:  Jarmila Machackova; Judit Barta; Naranjan S Dhalla
Journal:  Can J Cardiol       Date:  2006-09       Impact factor: 5.223

2.  Angiotensin II type1a receptor gene expression in the heart: AP-1 and GATA-4 participate in the response to pressure overload.

Authors:  T C Herzig; S M Jobe; H Aoki; J D Molkentin; A W Cowley; S Izumo; B E Markham
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

Review 3.  The role of thyroid hormone in the pathophysiology of heart failure: clinical evidence.

Authors:  E Galli; A Pingitore; G Iervasi
Journal:  Heart Fail Rev       Date:  2008-12-27       Impact factor: 4.214

4.  M-protein is down-regulated in cardiac hypertrophy driven by thyroid hormone in rats.

Authors:  Andrei Rozanski; Ana Paula C Takano; Patricia N Kato; Antonio G Soares; Camilo Lellis-Santos; Juliane Cruz Campos; Julio Cesar Batista Ferreira; Maria Luiza M Barreto-Chaves; Anselmo S Moriscot
Journal:  Mol Endocrinol       Date:  2013-10-31

5.  Adenovirus-mediated gene transfer using ex vivo perfusion of the heart graft.

Authors:  M Shiraishi; T Kusano; J Hara; S Hiroyasu; M Shao-Ping; Y Makino; Y Muto
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

6.  Altered tension cost in (TG(mREN-2)27) rats overexpressing the mouse renin gene.

Authors:  Carsten Zobel; Persephone Zavidou-Saroti; Birgit Bölck; Klara Brixius; Hannes Reuter; Konrad Frank; Holger Diedrichs; Jochen Müller-Ehmsen; Wilhelm Bloch; Robert H G Schwinger
Journal:  Eur J Appl Physiol       Date:  2006-10-25       Impact factor: 3.078

7.  Pulmonary artery smooth muscle hypertrophy: roles of glycogen synthase kinase-3beta and p70 ribosomal S6 kinase.

Authors:  Huan Deng; Marc B Hershenson; Jing Lei; Anuli C Anyanwu; David J Pinsky; J Kelley Bentley
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-02-26       Impact factor: 5.464

8.  Differential regulation of the myosin heavy chain genes alpha and beta in rat atria and ventricles: role of antisense RNA.

Authors:  Sara Danzi; Steven Klein; Irwin Klein
Journal:  Thyroid       Date:  2008-07       Impact factor: 6.568

9.  Transient cardiac expression of constitutively active Galphaq leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways.

Authors:  U Mende; A Kagen; A Cohen; J Aramburu; F J Schoen; E J Neer
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

10.  Metabolomic Profiles and Heart Failure Risk in Black Adults: Insights From the Jackson Heart Study.

Authors:  Usman A Tahir; Daniel H Katz; Tianyi Zhao; Debby Ngo; Daniel E Cruz; Jeremy M Robbins; Zsu-Zsu Chen; Bennet Peterson; Mark D Benson; Xu Shi; Lucas Dailey; Charlotte Andersson; Ramachandran S Vasan; Yan Gao; Changyu Shen; Adolfo Correa; Michael E Hall; Thomas J Wang; Clary B Clish; James G Wilson; Robert E Gerszten
Journal:  Circ Heart Fail       Date:  2021-01-19       Impact factor: 10.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.